Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX

BACKGROUND/AIMS: Although many studies have reported the promising effect of neoadjuvant treatment for borderline resectable pancreatic cancer (BRPC) to increase resectability, only a few studies have recommended the use of first-line chemotherapeutic agents as neoadjuvant treatment for BRPC. The cu...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Gut Liver
मुख्य लेखकों: Choi, Yoo Jin, Byun, Yoonhyeong, Kang, Jae Seung, Kim, Hyeong Seok, Han, Youngmin, Kim, Hongbeom, Kwon, Wooil, Oh, Do-Youn, Paik, Woo Hyun, Lee, Sang Hyub, Ryu, Ji Kon, Kim, Yong-Tae, Lee, Kyungbun, Kim, Haeryoung, Chie, Eui Kyu, Jang, Jin-Young
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Editorial Office of Gut and Liver 2021
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129663/
https://ncbi.nlm.nih.gov/pubmed/32839360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl20070
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन